However, a higher CD8:Tregs ratio was found for the Mit-A + αPD-L1 treatment group compared to the αPD-L1 monotherapy in both tumor and spleen (Figure 4D) suggesting that the combination treatment leads to higher T cell infiltration with suppression of the immunosuppressive Tregs cell population. This evidence concerns the gene CD8A and neoplasm.